1. Home
  2. EVAX vs TXMD Comparison

EVAX vs TXMD Comparison

Compare EVAX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EVAX

Evaxion Biotech

HOLD

Current Price

$3.20

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.22

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVAX
TXMD
Founded
2008
2008
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.4M
25.9M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
EVAX
TXMD
Price
$3.20
$2.22
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.33
N/A
AVG Volume (30 Days)
23.4K
27.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.61
EPS
N/A
N/A
Revenue
N/A
$1,761,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$90.64
Revenue Growth
N/A
35.25
52 Week Low
$1.20
$0.72
52 Week High
$12.15
$2.95

Technical Indicators

Market Signals
Indicator
EVAX
TXMD
Relative Strength Index (RSI) 43.92 50.56
Support Level $2.56 $1.05
Resistance Level $3.54 $2.54
Average True Range (ATR) 0.23 0.12
MACD 0.05 -0.02
Stochastic Oscillator 44.63 57.58

Price Performance

Historical Comparison
EVAX
TXMD

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: